Bruker Corporation (BRKRP) vs Vaxcyte, Inc. (PCVX)

A side-by-side comparison of Bruker Corporation and Vaxcyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BRKRP vs PCVX

growth of $100 · dividends reinvested · last 1y
BRKRP +94.8% (+94.8%/yr)PCVX +130.0% (+130.0%/yr)PCVX compounded faster over this window
100150200Start $1002026$195$230
BRKRP PCVX

BRKRP vs PCVX: by the numbers

  • •PCVX is the larger company ($9.63B vs $8.93B market cap).
  • •Both run net losses; PCVX's is the smaller (0.00% vs -2.03% net margin).
  • •BRKRP pays a dividend (3.35% yield), while PCVX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricBRKRPPCVX
Forward P/E209.72N/A
P/S ratio2.55N/A
P/B ratio3.723.49
EV / EBITDA29.89N/A
FCF yield1.05%N/A

Profitability

MetricBRKRPPCVX
Gross margin46.69%0.00%
Operating margin3.61%0.00%
Net margin-2.03%0.00%
ROE-2.97%-38.59%
ROIC2.56%-40.65%

Dividends

MetricBRKRPPCVX
Dividend yield3.35%N/A

Growth (annualized)

MetricBRKRPPCVX
Revenue CAGR (5Y)9.10%N/A
FCF CAGR (5Y)-21.33%N/A
Total return CAGR (5Y)N/A25.08%

Frequently asked

Does BRKRP or PCVX pay a bigger dividend?
BRKRP pays a dividend (3.35% yield), while PCVX has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.